Pathophysiology, diagnosis and medical treatment of non-calcium stones;Pathophysiologie, diagnostik und konservative therapie bei nicht-kalziumhaltigen nierensteinen

Therapeutische Umschau

Volumn 60, Issue 2, 2003, Pages 89-97

  Hochreiter, W ^a   Knoll, Th ^b   Hess, Bernhard ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Medizinische Klinik   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2,8 DIHYDROXYADENINE; ALLOPURINOL; APATITE; CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATE; CYSTINE; STRUVITE; UREASE; URIC ACID;

ALKALINIZATION; ARTICLE; CHRONIC DIARRHEA; CRYSTALLIZATION; CYSTINURIA; DEHYDRATION; DIET RESTRICTION; EXTRACORPOREAL LITHOTRIPSY; FLANK PAIN; FLUOROSCOPY; GOUT; HUMAN; HYDRATION; KIDNEY TUBULE DISORDER; NEPHROLITHIASIS; PURINE METABOLISM; RISK FACTOR; STAGHORN STONE; STONE FORMATION; URIC ACID STONE; URINARY TRACT INFECTION; URINE PH;

EID: 0037284215     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.60.2.89     Document Type: Article

References (37)

1. Glauser A, Hochreiter W, Jaeger Ph, Hess B. Determinations of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects. Nephrol Dial Transplant 2000; 15: 1580-7.
2. Hess B, Kok DJ. Nucleation, growth and aggregation of stone-forming crystals. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM eds. Kidney stones: medical and surgical management. Philadelphia: Lippincott-Raven, 1996: 3-32.
3. Brändle E, Hautmann R, Alken P, et al. Metaphylaxe des Harnsteinleidens. Urologe A 1997; 36: 588-93.
4. Hess B. Nephrolithiasis. Schweiz Med Forum 2002; 1: 1119-27.
5. Kramer G, Klingler HC, Steiner GE. Role of bacteria in the development of kidney stones. Curr Opin Urol 2000; 10: 35-8.
6. Menon M, Parulkar BG, Drach GW. Urinary Lithiasis: Etiology, diagnosis, and medical management. In: Walsh PC, Retik AB, Vaughan Jr. ED, Wein AJ, eds. Campbell's Urology, 7th ed., Philadelphia: W.B. Saunders, 1998: 2659-2733.
7. Griffith DP, Osborne CA. Infection (urease) stones. Miner Electrolyte Metab 1987; 13: 278-85.
8. Hess B, Ackermann D. Prophylaxe bei Infekt-, Harnsäure- und Zystinsteinen. Ther Umschau 1992; 49: 44-8.
9. Wang Y-H, Grenabo L, Hedelin H, Pettersson S. The effects of sodium citrate and oral potassium citrate on urease-induced crystallization. Br J Urol 1994; 74: 409-15.
10. Bruno D, Preminger GM. Noncalcium urinary calculi. In: Coe FL, Favus MJ eds. Disorders of bone and mineral metabolism, 2nd ed. Philadelphia: Lippincott, Willliams & Wilkins, 2002: 776-801.
11. Kamel KS, Cheema-Dhadli S, Halperin ML. Studies on the pathophysiology of the low urine pH in patients with uric acid stones. Kidney Int 2002; 61: 988-94.
12. Rodman JS, Sosa E, Lopez MA. Diagnosis and treatment of uric acid calculi. In: Coe FL et al. eds. Kidney stones: medical and surgical management. Philadelphia: Lippincott-Raven, 1996: 973-89.
13. Wahl Ch, Hess B. Nierensteine -ist die Ernährung Trigger oder Therapeutikum? Ther Umschau 2000; 57: 138-45.
14. Barbey F, Joly D, Rieu P, Mejean A, Daudon M, Jungers P. Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 2000; 163: 1419-23.
15. Sakhaee K, Sutton RAL. Cystinuria. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM eds. Kidney stones: medical and surgical management. Philadelphia: Lippincott-Raven, 1996: 1007-17.
16. Dent CE, Senior B. Studies on the treatment of cystinuria. Br J Urol 1955; 27: 317-25.
17. Leusmann DB, Blaschke R, Schmandt W. Results of 5,035 stone analyses: a contribution to epidemiology of urinary stone disease. Scand J Urol Nephrol 1990; 24: 205-10.
18. Bisceglia L, Calonge MJ, Totaro A et al. Localization by linkage analysis, of the cystinuria type III gene to chromosome 19q13.1. Am J Hum Genet 1997; 60: 611-6.
19. Goodyer P, Boutros M, Rozen R. The molecular basis of cystinuria: an update. Exp Nephrol 2000; 8: 123-7.
20. Goodyer P, Saadi I, Ong P, Elkas G, Rozen R. Cystinuria subtype and the risk of nephrolithiasis. Kidney Int 1998; 54: 56-61.
21. Darnell J, Lodis H, Baltimore D. Molecules in cells. In Molecular Cell Biology, 2nd ed. New York: WH Freeman, 1990: 43.
22. Evans WP, Resnick MI, Boyce WH. Homozygous cystinuria: evaluation of 35 patients. J Urol 1982; 127: 707-9.
23. Guillen M, Corella D, Cabello ML, Garcia AM, Hernandez-Yago J. Reference values of urinary excretion of cystine and dibasic aminoacids: classification of patients with cystinuria in the Valencian Community, Spain. Clin Biochem 1999; 32: 25-30.
24. Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL. Clinical use of cystine supersaturation measurements. J Urol 2000; 164: 1481-5.
25. Deutsche Gesellschaft für Urologie, Arbeitskreis Harnsteine. Urologe A, 1997: 588
26. Monnens LA, Noordam K, Trijbels F. Necessary practical treatment of cystinuria at night. Pediatr Nephrol 2000; 14: 1148-9.
27. Jaeger P, Portmann L, Saunders A, Rosenberg LE, Thier SO. Anticystinuric effects of glutamine and dietary sodium restriction. N. Engl J Med 1986; 143: 1120-3.
28. Pak CYC. Cystine lithiasis. In: Resnick MI, Pak CYC eds. Urolithiasis: a medical and surgical Reference. Philadelphia: WB Saunders, 1994:
29. Akakura K, Egoshi K, Ueda T et al. The long-term outcome of cystinuria in Japan. Urol Int 1998; 61: 86-9.
30. Pak CYC, Fuller C, Sakhaee K, Zerwekh JH, Adams BV. Management of cystine nephrolithiasis with alpha-mercaptoproprionylglycine. J Urol 1986; 136: 1003-8.
31. Harbar JA, Cusworth DC, Lawes LC, Wrong OM. Comparison of 2-mercapto-propionylglycine and D-penicillamine in the treatment of cystinuria. J Urol 1986; 136: 146-9.
32. Tekin A, Tekgul S, Atsu N, Sahin A, Bakkaloglu M. Cystine calculi in children: the results of a metabolic evaluation and response to medical therapy. J Urol 2001; 165: 2328-30.
33. Lux B, May P. Long-term observation of young cystinuric patients under ascorbic acid therapy. Urol Int 1983; 38: 91-4.
34. Ragone R. Medical treatment of cystinuria with vitamin C. Am J Kidney Dis 2000; 35: 1020 (letter).
35. Simmonds HA, van Acker KJ, Sahota AS. The identification of 2,8-dihydroxy adenine, a new component of urinary stones. Biochem J 1976; 157: 485-7.
36. Hesse A, Miersch WD, Classen A, Thon A, Doppler W. 2,8-Dihydroxyadeninuria: laboratory diagnosis and therapy control. Urol Int 1988; 43: 174-8.
37. Coe FL; Straus AL, Tembe V, Dun SL. Uric acid saturation in calcium nephrolithiasis. Kidney Int 1980; 17: 662-8.